IPM's CEO on Milestone for Women's HIV Prevention from zeda Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: IPM's CEO Zeda Rosenberg welcomes the European Medicines Agency's positive scientific opinion for the dapivirine vaginal ring for use by women ages 18 and older to reduce their HIV risk. The monthly ring, which was developed by IPM, is the first long-acting HIV prevention product.
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)